UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

March 35, 2026

Date of Report (Date of earliest event reported)

Quipt Home Medical Corp.

(Exact name of registrant as specified in its charter)

British Columbia, Canada

(State or other jurisdiction of incorporation)

001-40413		N/A
(Commission File Number)		(IRS Employer Identification No.)

1019 Town Drive
Wilder, Kentucky		41076
(Address of principal executive offices)		(Zip Code)

(859) 878-2220

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Shares, without Par Value	QIPT	The Nasdaq Capital Market
		Toronto Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5 8.0701. ~~Submission~~Other ~~of Matters to a Vote of Security Holders~~Events.

On March 3 5, 2026, Quipt Home Medical Corp. (“Quipt”) ~~convened a special meeting (the “Meeting”) of the holders of common shares (the “Shares”)~~ ofannounced ~~Quipt~~that ~~(collectively,~~it ~~the~~obtained ~~“Shareholders”) to vote on~~ a ~~proposal~~final ~~to consider, pursuant to an interim~~ order offrom the Supreme Court of British Columbia, ~~dated~~approving asthe ofpreviously ~~January 23,~~announced ~~2026,~~plan ~~and,~~of ~~if deemed advisable, to pass, with or without variation, a special~~arrangement ~~resolution~~ (the “Arrangement ~~Resolution~~”), ~~approving an arrangement~~ under Division 5 of Part 9 of the Business Corporations Act (British Columbia) pursuant to the Arrangement ~~arrangement agreement~~Agreement, dated ~~as of~~ December 14, 2025, by and among Quipt, 1567208 B.C. Ltd., and REM Aggregator, LLC. The Arrangement Resolution is described in more detail in the definitive management information circular and proxy statement filed with the Securities and Exchange Commission by Quipt on February 4, 2026.

AsThe ofArrangement ~~the~~is ~~close~~subject ofto ~~business on January 22,~~customary ~~2026,~~closing ~~the~~conditions. ~~record~~Subject ~~date~~to of the ~~Meeting,~~satisfaction ~~there~~of ~~were~~such 44conditions,~~329,972~~ ~~Shares~~the ~~issued~~transaction ~~and~~is ~~outstanding~~expected ~~and entitled~~ to ~~vote.~~be Acompleted ~~total~~by 29March 16,~~672,136~~ ~~Shares were~~2026. ~~voted~~Following atclosing of the ~~Meeting~~Arrangement, ~~representing~~Quipt’s ~~approximately~~common ~~66.93%~~shares ofwill ~~the~~be ~~issued~~delisted ~~and~~from ~~outstanding~~the ~~Shares~~Toronto asStock ofExchange (“TSX”) and the ~~record~~Nasdaq ~~date~~Capital Market (“NASDAQ”).

~~The~~A ~~number~~copy of ~~votes cast for and against~~ the ~~Arrangement~~ ~~Resolution~~press isrelease ~~set~~issued ~~out~~by ~~below.~~Quipt ~~There~~on March ~~were~~5, no2026 ~~recorded~~is ~~abstentions~~attached oras ~~broker~~Exhibit ~~non-votes~~99.1 ~~with respect~~ to ~~the~~this ~~Arrangement~~Current ~~Resolution. Set~~Report ~~forth~~on ~~below~~Form ~~are the results of the Meeting:~~8-K.

~~The~~Cautionary ~~Arrangement~~Note ~~Resolution~~Regarding Forward-Looking Statements

~~The~~Certain ~~Arrangement~~statements ~~Resolution~~contained ~~was~~in ~~approved,~~this ~~receiving~~report constitute “forward-looking statements” within the ~~affirmative~~meaning ~~vote~~of the U.S. Private Securities Litigation Reform Act of ~~approximately~~1995 or “forward-looking information” as such term is defined in applicable Canadian securities legislation (icollectively, “forward-looking statements”). The 98words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “postulate”, “expect”, “outlook”, or the negatives thereof or variations of such words, and similar expressions as they relate to Quipt are intended to identify forward-looking statements, including: the proposed Arrangement and terms thereof; and other statements that are not historical fact.9% All statements other than statements of historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the ~~votes~~forward-looking ~~cast~~statements. bySuch ~~Shareholders~~statements reflect Quipt’s current views and intentions with respect to future events, ~~present~~and current information available to Quipt, and are subject to certain risks, uncertainties and assumptions, including, without limitation: the ability to obtain the necessary regulatory and other third party approvals for the Arrangement, the timing of obtaining such approvals and the risk that such approvals may not be obtained in ~~person~~a timely manner or at ~~represented~~all, byand ~~proxy~~the atrisk that such approvals may be obtained on conditions that are not anticipated; the anticipated completion of the Arrangement and timing thereof; the ~~Meeting~~abilities of the parties to satisfy, in a timely manner, the other conditions to the closing of the Arrangement; the delisting of the common shares of Quipt from the TSX and ~~(ii)~~NASDAQ; 98Quipt ceasing to be a reporting issuer under Canadian and U.7%S. federal securities laws and the timing thereof; the failure of the ~~votes~~Arrangement ~~cast~~to byclose ~~Shareholders~~for any other reason; and the ability to achieve the expected benefits of the Arrangement. Many factors could cause the actual results, ~~present~~performance inor ~~person~~achievements that may be expressed or ~~represented~~implied by ~~proxy~~such forward-looking statements to vary from those described herein should one or more of these risks or uncertainties materialize. Examples of such risk factors include, without limitation: risks related to credit, market (including equity, commodity, foreign exchange and ~~entitled~~interest rate), liquidity, operational (including technology and infrastructure), reputational, insurance, strategic, regulatory, legal, environmental, and capital adequacy; the general business and economic conditions in the regions in which Quipt operates; the ability of Quipt to ~~vote~~execute aton key priorities, including the successful completion of acquisitions, business retention, and strategic plans and to attract, develop and retain key executives; difficulty integrating newly acquired businesses; the ~~Meeting~~ability to implement business strategies and pursue business opportunities; low profit market segments; disruptions in or attacks (including cyber-attacks) on Quipt’s information technology, ~~after~~internet, ~~excluding~~network access or other voice or data communications systems or services; the ~~votes~~evolution ~~cast~~of various types of fraud or other criminal behavior to which Quipt is exposed; the failure of third parties to comply with their obligations to Quipt or its affiliates; the impact of new and changes to, or application of, current laws and regulations; decline of reimbursement rates; dependence on few payors; possible new drug discoveries; a novel business model; dependence on key suppliers; granting of permits and licenses in a highly regulated business; legal proceedings and litigation, including as it relates to the civil investigative demand received from the Department of Justice; increased competition; changes in foreign currency rates; the imposition of trade restrictions such as tariffs and retaliatory counter measures; increased funding costs and market volatility due to market illiquidity and competition for funding; the availability of funds and resources to pursue operations; critical accounting estimates and changes to accounting standards, policies, and methods used by Quipt; Quipt’s status as an emerging growth company and a smaller reporting company; the ~~Shareholders~~occurrence of ~~whose~~natural ~~votes~~and ~~are~~unnatural ~~required~~catastrophic events or health epidemics or concerns; as well as those risk factors discussed or referred to in beQuipt’s ~~excluded~~disclosure ~~under~~documents ~~Multilateral~~filed ~~Instrument~~with the SEC and available on EDGAR at www.sec.gov, including Quipt’s most recent Annual 61Report on Form 10-~~101~~K and subsequent Quarterly Reports on Form 10-Q, ~~Protection~~and with the securities regulatory authorities in certain provinces of ~~Minority~~Canada ~~Security~~and ~~Holders~~available at www.sedarplus.ca. Should any factor affect Quipt in ~~Special~~an ~~Transactions~~unexpected manner, or should assumptions underlying the forward-looking statement prove incorrect, the actual results or events may differ materially from the results or events predicted. Any Insuch ~~respect~~forward-looking statements are expressly qualified in their entirety by this cautionary statement. Moreover, Quipt does not assume responsibility for the accuracy or completeness of such forward-looking statements. The forward-looking statements included in this report are made as of the ~~preceding~~date ~~two~~of ~~clauses,~~this ~~votes~~report ~~were~~and Quipt undertakes no obligation to publicly update or revise any forward-looking ~~received~~statements, other than as ~~follows:~~required by applicable law.‎

~~(i)~~Item 9.01. Financial Statements and Exhibits.

Votes For		% Votes For		Votes Against		% Votes Against
28,737,677		98.9%		319,623		1.1%

(d) Exhibits:

(ii)

Exhibit Number		Description
99.1		Press release issued by Quipt Home Medical Corp. on March 5, 2026
104		Cover Page Interactive Data File (formatted as Inline XBRL and embedded within the Inline XBRL document)

Votes For		% Votes For		Votes Against		% Votes Against
23,929,010		98.68%		319,623		1.32%

SIGNATURES

~~Item~~Pursuant ~~8.01.~~to ~~Other~~the ~~Events~~requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

On March 3, 2026, Quipt issued a press release containing information about the voting results of the Meeting. A copy of this press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

		Quipt Home Medical Corp.

Date:	March 5, 2026	By:	/s/ Hardik Mehta
			Hardik Mehta
			Chief Financial Officer

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit Number		Description
99.1		Press release issued by Quipt Home Medical Corp. on March 3, 2026
104		Cover Page Interactive Data File (formatted as Inline XBRL and embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

		Quipt Home Medical Corp.
Date:	March 3, 2026	By:	/s/ Hardik Mehta
			Hardik Mehta
			Chief Financial Officer

Filing Compare · Quipt Home Medical Corp.